Selected research
Market Structure
Global Medical Polyglycolic Acid (PGA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Polyglycolic Acid (PGA) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Polyglycolic Acid (PGA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Polyglycolic Acid (PGA) include Sinopec, Yulin Energy Group, Evonik, Shanghai Pujing Chemical, Huayang Medical, Danhua Technology, Shenzhen Polymtek Biomaterial and Kureha, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Medical Polyglycolic Acid (PGA) output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Medical Polyglycolic Acid (PGA) by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Medical Polyglycolic Acid (PGA) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Polyglycolic Acid (PGA) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Polyglycolic Acid (PGA) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Polyglycolic Acid (PGA) market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Polyglycolic Acid (PGA) Segment by Company
Sinopec
Yulin Energy Group
Evonik
Shanghai Pujing Chemical
Huayang Medical
Danhua Technology
Shenzhen Polymtek Biomaterial
Kureha
Medical Polyglycolic Acid (PGA) Segment by Type
Copolymer
Homopolymer
Block Copolymers
Medical Polyglycolic Acid (PGA) Segment by Application
Tissue Engineering Scaffold
Medical Suture
Drug Controlled Release Carrier
Fracture Fixation Material
Stitched Reinforcement Material
Medical Polyglycolic Acid (PGA) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polyglycolic Acid (PGA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Polyglycolic Acid (PGA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polyglycolic Acid (PGA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Polyglycolic Acid (PGA) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Polyglycolic Acid (PGA) industry.
Chapter 3: Detailed analysis of Medical Polyglycolic Acid (PGA) market competition landscape. Including Medical Polyglycolic Acid (PGA) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Medical Polyglycolic Acid (PGA) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Medical Polyglycolic Acid (PGA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Copolymer
- Homopolymer
- Block Copolymers
Applications
- Tissue Engineering Scaffold
- Medical Suture
- Drug Controlled Release Carrier
- Fracture Fixation Material
- Stitched Reinforcement Material
Companies covered
- Sinopec
- Yulin Energy Group
- Evonik
- Shanghai Pujing Chemical
- Huayang Medical
- Danhua Technology
- Shenzhen Polymtek Biomaterial
- Kureha
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Medical Polyglycolic Acid (PGA) Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Medical Polyglycolic Acid (PGA) Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Medical Polyglycolic Acid (PGA) Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Medical Polyglycolic Acid (PGA) Market Dynamics
- 2.1 Medical Polyglycolic Acid (PGA) Industry Trends
- 2.2 Medical Polyglycolic Acid (PGA) Industry Drivers
- 2.3 Medical Polyglycolic Acid (PGA) Industry Opportunities and Challenges
- 2.4 Medical Polyglycolic Acid (PGA) Industry Restraints
3 Medical Polyglycolic Acid (PGA) Market by Manufacturers
- 3.1 Global Medical Polyglycolic Acid (PGA) Production Value by Manufacturers (2021-2026)
- 3.2 Global Medical Polyglycolic Acid (PGA) Production by Manufacturers (2021-2026)
- 3.3 Global Medical Polyglycolic Acid (PGA) Average Price by Manufacturers (2021-2026)
- 3.4 Global Medical Polyglycolic Acid (PGA) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Polyglycolic Acid (PGA) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Polyglycolic Acid (PGA) Manufacturers, Product Type & Application
- 3.7 Global Medical Polyglycolic Acid (PGA) Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Polyglycolic Acid (PGA) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Polyglycolic Acid (PGA) Players Market Share by Production Value in 2025
- 3.8.3 2025 Medical Polyglycolic Acid (PGA) Tier 1, Tier 2, and Tier 3
4 Medical Polyglycolic Acid (PGA) Market by Type
- 4.1 Medical Polyglycolic Acid (PGA) Type Introduction
- 4.1.1 Copolymer
- 4.1.2 Homopolymer
- 4.1.3 Block Copolymers
- 4.2 Global Medical Polyglycolic Acid (PGA) Production by Type
- 4.2.1 Global Medical Polyglycolic Acid (PGA) Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Polyglycolic Acid (PGA) Production by Type (2021-2032)
- 4.2.3 Global Medical Polyglycolic Acid (PGA) Production Market Share by Type (2021-2032)
- 4.3 Global Medical Polyglycolic Acid (PGA) Production Value by Type
- 4.3.1 Global Medical Polyglycolic Acid (PGA) Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Polyglycolic Acid (PGA) Production Value by Type (2021-2032)
- 4.3.3 Global Medical Polyglycolic Acid (PGA) Production Value Market Share by Type (2021-2032)
5 Medical Polyglycolic Acid (PGA) Market by Application
- 5.1 Medical Polyglycolic Acid (PGA) Application Introduction
- 5.1.1 Tissue Engineering Scaffold
- 5.1.2 Medical Suture
- 5.1.3 Drug Controlled Release Carrier
- 5.1.4 Fracture Fixation Material
- 5.1.5 Stitched Reinforcement Material
- 5.2 Global Medical Polyglycolic Acid (PGA) Production by Application
- 5.2.1 Global Medical Polyglycolic Acid (PGA) Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Polyglycolic Acid (PGA) Production by Application (2021-2032)
- 5.2.3 Global Medical Polyglycolic Acid (PGA) Production Market Share by Application (2021-2032)
- 5.3 Global Medical Polyglycolic Acid (PGA) Production Value by Application
- 5.3.1 Global Medical Polyglycolic Acid (PGA) Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Polyglycolic Acid (PGA) Production Value by Application (2021-2032)
- 5.3.3 Global Medical Polyglycolic Acid (PGA) Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sinopec
- 6.1.1 Sinopec Company Information
- 6.1.2 Sinopec Business Overview
- 6.1.3 Sinopec Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.1.4 Sinopec Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.1.5 Sinopec Recent Developments
- 6.2 Yulin Energy Group
- 6.2.1 Yulin Energy Group Company Information
- 6.2.2 Yulin Energy Group Business Overview
- 6.2.3 Yulin Energy Group Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.2.4 Yulin Energy Group Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.2.5 Yulin Energy Group Recent Developments
- 6.3 Evonik
- 6.3.1 Evonik Company Information
- 6.3.2 Evonik Business Overview
- 6.3.3 Evonik Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.3.4 Evonik Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.3.5 Evonik Recent Developments
- 6.4 Shanghai Pujing Chemical
- 6.4.1 Shanghai Pujing Chemical Company Information
- 6.4.2 Shanghai Pujing Chemical Business Overview
- 6.4.3 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.4.4 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.4.5 Shanghai Pujing Chemical Recent Developments
- 6.5 Huayang Medical
- 6.5.1 Huayang Medical Company Information
- 6.5.2 Huayang Medical Business Overview
- 6.5.3 Huayang Medical Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.5.4 Huayang Medical Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.5.5 Huayang Medical Recent Developments
- 6.6 Danhua Technology
- 6.6.1 Danhua Technology Company Information
- 6.6.2 Danhua Technology Business Overview
- 6.6.3 Danhua Technology Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.6.4 Danhua Technology Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.6.5 Danhua Technology Recent Developments
- 6.7 Shenzhen Polymtek Biomaterial
- 6.7.1 Shenzhen Polymtek Biomaterial Company Information
- 6.7.2 Shenzhen Polymtek Biomaterial Business Overview
- 6.7.3 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.7.4 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.7.5 Shenzhen Polymtek Biomaterial Recent Developments
- 6.8 Kureha
- 6.8.1 Kureha Company Information
- 6.8.2 Kureha Business Overview
- 6.8.3 Kureha Medical Polyglycolic Acid (PGA) Production, Value and Gross Margin (2021-2026)
- 6.8.4 Kureha Medical Polyglycolic Acid (PGA) Product Portfolio
- 6.8.5 Kureha Recent Developments
7 Global Medical Polyglycolic Acid (PGA) Production by Region
- 7.1 Global Medical Polyglycolic Acid (PGA) Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Medical Polyglycolic Acid (PGA) Production by Region (2021-2032)
- 7.2.1 Global Medical Polyglycolic Acid (PGA) Production by Region (2021-2026)
- 7.2.2 Global Medical Polyglycolic Acid (PGA) Production Forecast by Region (2027-2032)
- 7.3 Global Medical Polyglycolic Acid (PGA) Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Medical Polyglycolic Acid (PGA) Production Value by Region (2021-2032)
- 7.4.1 Global Medical Polyglycolic Acid (PGA) Production Value by Region (2021-2026)
- 7.4.2 Global Medical Polyglycolic Acid (PGA) Production Value by Region (2027-2032)
- 7.5 Global Medical Polyglycolic Acid (PGA) Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Medical Polyglycolic Acid (PGA) Production Value (2021-2032)
- 7.6.2 Europe Medical Polyglycolic Acid (PGA) Production Value (2021-2032)
- 7.6.3 Asia-Pacific Medical Polyglycolic Acid (PGA) Production Value (2021-2032)
- 7.6.4 South America Medical Polyglycolic Acid (PGA) Production Value (2021-2032)
- 7.6.5 Middle East & Africa Medical Polyglycolic Acid (PGA) Production Value (2021-2032)
8 Global Medical Polyglycolic Acid (PGA) Consumption by Region
- 8.1 Global Medical Polyglycolic Acid (PGA) Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Medical Polyglycolic Acid (PGA) Consumption by Region (2021-2032)
- 8.2.1 Global Medical Polyglycolic Acid (PGA) Consumption by Region (2021-2026)
- 8.2.2 Global Medical Polyglycolic Acid (PGA) Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Polyglycolic Acid (PGA) Value Chain Analysis
- 9.1.1 Medical Polyglycolic Acid (PGA) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Polyglycolic Acid (PGA) Production Mode & Process
- 9.2 Medical Polyglycolic Acid (PGA) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Polyglycolic Acid (PGA) Distributors
- 9.2.3 Medical Polyglycolic Acid (PGA) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst